Simcere Zaiming, Inc., Insider at NextCure, Inc. (NXTC), sold 30,000 shares at $6.16 ($185K) on 2026-08-10, disclosed to the SEC on 2026-08-12.
Open-market sale of $185k NXTC by Insider. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.